Danenberg Noam 4
4 · Wize Pharma, Inc. · Filed Sep 16, 2019
Insider Transaction Report
Form 4
Danenberg Noam
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2019-06-30+17,500→ 142,500 total - Exercise/Conversion
Restricted Stock Units (RSU)
2019-06-30−17,500→ 122,500 total→ Common Stock (17,500 underlying)
Footnotes (2)
- [F1]Each RSU represents a right to receive one share of Wize Pharma, Inc. common stock.
- [F2]On March 31, 2019, the reporting person was granted 140,000 restricted stock units, vesting quarterly over a two-year period with the first installment issued on June 30, 2019.